These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23026688)

  • 41. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study.
    Kukino J; Naito T; Mitsuhashi K; Oshima H; Sekiya S; Isonuma H; Watanabe K; Dambara T; Hayashida Y
    J Infect Chemother; 2004 Dec; 10(6):335-7. PubMed ID: 15614457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethics of vaccination programs.
    Schwartz JL; Caplan AL
    Curr Opin Virol; 2011 Oct; 1(4):263-7. PubMed ID: 22440783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G; Ferrarini G; Rigolin F; Bogaerts H; André FE
    Helv Paediatr Acta; 1986 Aug; 41(3):203-8. PubMed ID: 3019954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The timing of tuberculin tests in relation to immunization with live viral vaccines.
    Brickman HF; Beaudry PH; Marks MI
    Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Biotechnology for the benefit of vaccination against viral diseases: a review].
    van Oirschot JT
    Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
    Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
    Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vaccinations in childhood: when and why].
    Ugazio AG; Plebani A
    Recenti Prog Med; 1993 Dec; 84(12):864-72. PubMed ID: 8108602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Present issues in antiviral vaccines (author's tranls)].
    Pauluzzi S
    Ann Sclavo; 1979; 21(6):823-35. PubMed ID: 554552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vaccination against varicella].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):321-4. PubMed ID: 7491430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wanted, dead or alive: new viral vaccines.
    Amanna IJ; Slifka MK
    Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.
    Anderson AJ; Snelling TL; Moore HC; Blyth CC
    Paediatr Drugs; 2017 Dec; 19(6):523-531. PubMed ID: 28808938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA; Novelli VM; Lipton SV; Pollock B
    Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
    Lum LC; Borja-Tabora CF; Breiman RF; Vesikari T; Sablan BP; Chay OM; Tantracheewathorn T; Schmitt HJ; Lau YL; Bowonkiratikachorn P; Tam JS; Lee BW; Tan KK; Pejcz J; Cha S; Gutierrez-Brito M; Kaltenis P; Vertruyen A; Czajka H; Bojarskas J; Brooks WA; Cheng SM; Rappaport R; Baker S; Gruber WC; Forrest BD
    Vaccine; 2010 Feb; 28(6):1566-74. PubMed ID: 20003918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunization and prevention of infectious diseases of children].
    Ueda K
    Fukuoka Igaku Zasshi; 1984 Sep; 75(9):520-3. PubMed ID: 6097523
    [No Abstract]   [Full Text] [Related]  

  • 60. Rotavirus vaccines against diarrhoeal disease.
    Vesikari T
    Lancet; 1997 Nov; 350(9090):1538-41. PubMed ID: 9388411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.